May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Chemokine Expression in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice
Author Affiliations & Notes
  • E.K. Akpek
    Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, United States
  • D.A. Jabs
    Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, United States
  • J. Whittum-Hudson
    Department of Medicine, Wayne State University, Detroit, MI, United States
  • B. Lee
    Department of Medicine, Wayne State University, Detroit, MI, United States
  • H. Gerard
    Department of Medicine, Wayne State University, Detroit, MI, United States
  • A.P. Hudson
    Department of Medicine, Wayne State University, Detroit, MI, United States
  • R.A. Prendergast
    Department of Medicine, Wayne State University, Detroit, MI, United States
  • Footnotes
    Commercial Relationships  E.K. Akpek, None; D.A. Jabs, None; J. Whittum-Hudson, None; B. Lee, None; H. Gerard, None; A.P. Hudson, None; R.A. Prendergast, None.
  • Footnotes
    Support  NEI Grant EY 05912, and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1022. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      E.K. Akpek, D.A. Jabs, J. Whittum-Hudson, B. Lee, H. Gerard, A.P. Hudson, R.A. Prendergast; Chemokine Expression in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1022.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: MRL/MpJ-fas+/fas+(MRL/+) and MRL/MpJ-faslpr/faslpr (MRL/lpr) mice are congeneic substrains that spontaneously develop destructive inflammation of the lacrimal and salivary glands, representing a model for human Sjögren’s syndrome. Previous work on cytokine expression profiles suggested that these lacrimal gland lesions appear to be largely T helper (Th) 2-driven. In this study, the relative contributions of chemokines MCP-1 and MCP-5, implicating Th2 and Th1 immune responses respectively, were assessed. Methods: Lacrimal glands were harvested from MRL/+ and MRL/lpr mice, at ages 6 weeks through 9 months. ABC staining on frozen sections and real time RT-PCR on the extracted RNA were performed to quantify the chemokine expression profiles. Age-matched BALB/c mice were used as controls. Results: Immunohistochemical studies demonstrated a significantly greater proportion of cells in the lacrimal gland lesions staining for MCP-1 (29 to 48% of total inflammatory cells depending on age) as compared to MCP-5 (1 to 3% of total inflammatory cells depending on age) both in MRL/+ (mean difference 34.2%, p<0.001) and MRL/lpr (mean difference 33.6%, p<0.001) substrains. Real time RT-PCR analyses showed a 2- to 110-fold higher transcript levels of MCP-1 as compared to MCP-5, in both MRL/+ (2.6 to 66.9 depending on age) and MRL/lpr (23.6 to 110.4 depending on age) mice, confirming the immunohistochemistry results. The ratio of MCP-1 to MCP-5 mRNA transcripts increased with increasing age and extent of disease in both substrains. Conclusions: The chemokine expression profile is consistent with the concept that the lacrimal gland lesions in MRL/MpJ mice are largely Th2-mediated.

Keywords: lacrimal gland • inflammation • pathology: experimental 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×